These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 770365)

  • 1. 5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depressions. A double-blind controlled study.
    Aliño JJ; Gutierrez JL; Iglesias ML
    Int Pharmacopsychiatry; 1976; 11(1):8-15. PubMed ID: 770365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New therapeutic possibilities in depression: 5-hydroxytryptophan].
    López-Ibor Aliño JJ; Ayuso Gutiérrez JL; Montejo Iglesias ML
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1975; 3(3):151-62. PubMed ID: 1099879
    [No Abstract]   [Full Text] [Related]  

  • 3. Tryptophan and an MAOI (nialamide) in the treatment of depression. A double-blind study.
    Ayuso Gutierrez JL; Aliño JJ
    Int Pharmacopsychiatry; 1971; 6(2):92-7. PubMed ID: 4950287
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of depression with L-5-hydroxytryptophan versus imipramine. Results of two open and one double-blind study.
    Angst J; Woggon B; Schoepf J
    Arch Psychiatr Nervenkr (1970); 1977 Oct; 224(2):175-86. PubMed ID: 336002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychopharmacologic treatment with (L-5-HTP), L-5 hydroxytryptophan in endogenous depressions].
    Sano I
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(1):223-31. PubMed ID: 4541701
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of 5-hydroxytryptophan on depression and apathy in Parkinson's disease: a preliminary finding.
    Meloni M; Puligheddu M; Carta M; Cannas A; Figorilli M; Defazio G
    Eur J Neurol; 2020 May; 27(5):779-786. PubMed ID: 32067288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a levo-5-hydroxytryptophan-dihydroergocristine combination on depression and neuropsychic performance: a double-blind placebo-controlled clinical trial in elderly patients.
    Rousseau JJ
    Clin Ther; 1987; 9(3):267-72. PubMed ID: 3111702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant potentiation of 5-hydroxytryptophan by L-deprenil in affective illness.
    Mendlewicz J; Youdim MB
    J Affect Disord; 1980 Jun; 2(2):137-46. PubMed ID: 6448885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-tryptophan and 5-hydroxytryptophan in the treatment of depression. A review.
    d'Elia G; Hanson L; Raotma H
    Acta Psychiatr Scand; 1978 Mar; 57(3):239-52. PubMed ID: 347886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode.
    Jangid P; Malik P; Singh P; Sharma M; Gulia AK
    Asian J Psychiatr; 2013 Feb; 6(1):29-34. PubMed ID: 23380314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of depression with L-5-hydroxytryptophan combined with chlorimipramine, a double-blind study.
    Nardini M; De Stefano R; Iannuccelli M; Borghesi R; Battistini N
    Int J Clin Pharmacol Res; 1983; 3(4):239-50. PubMed ID: 6381336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-hydroxytryptophan in combination with clomipramine in "therapy-resistant" depressions.
    van Praag HM; van den Burg W; Bos ER; Dols LC
    Psychopharmacologia; 1974; 38(3):267-9. PubMed ID: 4547418
    [No Abstract]   [Full Text] [Related]  

  • 13. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan.
    Turner EH; Loftis JM; Blackwell AD
    Pharmacol Ther; 2006 Mar; 109(3):325-38. PubMed ID: 16023217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["Precursor therapy" with active amines. I. Treatment of depression by L-5-HTP (L-5-hydroxytryptophan)].
    Sano I
    Seishin Shinkeigaku Zasshi; 1971 Oct; 73(10):809-15. PubMed ID: 5316872
    [No Abstract]   [Full Text] [Related]  

  • 15. [L-5-hydroxytryptophan(L-5-HTP) therapy in endogenous depression. 1].
    Sano I
    Munch Med Wochenschr; 1972 Oct; 114(40):1713-6. PubMed ID: 4538892
    [No Abstract]   [Full Text] [Related]  

  • 16. L-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebo-controlled study. For the Portuguese Head Society.
    Ribeiro CA
    Headache; 2000 Jun; 40(6):451-6. PubMed ID: 10849040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of essential headache in developmental age with L-5-HTP (cross over double-blind study versus placebo)].
    Longo G; Rudoi I; Iannuccelli M; Strinati R; Panizon F
    Pediatr Med Chir; 1984; 6(2):241-5. PubMed ID: 6397729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [L-5-hydroxytryptophan(L-5-HTP) therapy of Parkinson's disease. 2].
    Sano I; Taniguchi K
    Munch Med Wochenschr; 1972 Oct; 114(40):1717-9. PubMed ID: 4538893
    [No Abstract]   [Full Text] [Related]  

  • 19. Measurement of 5-hydroxyindole compounds during L-5-HTP treatment in depressed patients.
    Takahashi S; Takahashi R; Masumura I; Miike A
    Folia Psychiatr Neurol Jpn; 1976; 30(4):461-73. PubMed ID: 1087913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome.
    Caruso I; Sarzi Puttini P; Cazzola M; Azzolini V
    J Int Med Res; 1990; 18(3):201-9. PubMed ID: 2193835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.